SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is currently in the spotlight as investors weigh its pivot toward the high-growth AI infrastructure market against mixed financial performance. The community is heavily focused on the company's reinstated bookings guidance and reports of significant capacity interest from major hyperscalers, leading to a polarized debate between long-term bullish sentiment and concerns over near-term revenue volatility.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors react to a second round of subscription price increases across all tiers, a move aimed at boosting margins and funding a massive content budget. The stock is exhibiting notable relative strength, with community members actively discussing a potential breakout toward the 100 level and debating whether this pricing power effectively offsets broader streaming sector headwinds.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are actively discussing a potential relisting and the company's recent strategic moves, including the acquisition of Blue Bottle operations, as they weigh the stock's long-term global ecosystem potential against current OTC volatility. The community remains focused on valuation gaps, signs of institutional accumulation, and the end of intense local price wars that previously pressured margins.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology (STX) is trending as institutional analysts aggressively upgrade price targets, citing a structural expansion in the hard disk drive cycle and sustained hyperscaler demand. While the stock has seen significant volatility, community discussion remains divided between those betting on long-term data center supply shortages through 2028 and others cautioning against an overheated memory sector.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant volatility and intense community debate following a reverse stock split, with retail investors deeply divided between those betting on a potential short squeeze driven by institutional interest and those capitulating due to a lack of clear management guidance. While some traders view the current depressed price as an oversold buying opportunity, others are actively shorting the stock, citing ongoing concerns about the company's financial transparency and competitive position.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors debate whether recent production challengesspecifically laser dicing issues at their Malaysia facilityrepresent a major setback or a solvable engineering hurdle on the path to high-volume commercialization. The community is heavily split between long-term bulls highlighting institutional interest and potential partnerships, and skeptical traders who are focused on the stock's recent decline toward all-time lows and a perceived lack of immediate, large-scale purchase orders.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending after receiving FDA approval for VYKAT XR, the first and only treatment for hyperphagia in Prader-Willi syndrome, triggering a major rally and intense community speculation regarding potential buyout interest. Investors are closely monitoring the commercial launch strategy and the company's valuation, as many compare the setup to previous rare disease success stories while discussing the stock's long-term momentum.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is currently trending as investors focus on the upcoming earnings report and expectations for fiscal 2027 guidance and royalty backlog updates. The community remains highly polarized, with intense debate between long-term "believers" who highlight QNX's role in the software-defined vehicle market and skeptics who express frustration over stagnant stock performance and past revenue trends.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant community buzz driven by its low circulating supply and market cap, which proponents believe positions the token for a massive supply shock if volume spikes. While some investors express skepticism regarding its historical performance and lack of adoption, others are actively accumulating in anticipation of a potential breakout fueled by its DeFi and NFT platform integration.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is trending as investors closely monitor the upcoming release of pivotal biomarker data, which the community believes will serve as the primary catalyst for an FDA accelerated approval pathway for its ALS candidate, CNM-Au8. Market participants are actively debating the regulatory roadmap, the impact of recent insider selling, and how upcoming data will influence the company's valuation as it heads toward a high-stakes meeting with the FDA.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inventiva (NASDAQ:IVA) Shares Gap Down After Earnings Miss

Inventiva (NASDAQ:IVA) Shares Gap Down on Disappointing Earnings...

Inventiva Q4 Earnings Call Highlights

Inventiva (NASDAQ:IVA) used its full-year 2025 results call to outline a company-wide focus on advancing its lead candidate lanifibranor toward a potential approval in metabolic...

Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre-market after mixed Q4 results and lower sales guidance. Other stocks also decline.read more...

Inventiva (NASDAQ:IVA) Releases Quarterly Earnings Results

Inventiva (NASDAQ:IVA - Get Free Report) issued its earnings results on Monday. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.57). The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $8.67...

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update

Inventiva S.A. Sponsored ADR (NASDAQ:IVA - Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 447,124 shares, a decrease of 18.7% from the February 26th total of 549,755 shares. Currently, 0.5% of...

Inventiva (NASDAQ:IVA) Shares Gap Up   - Here's Why

Inventiva (NASDAQ:IVA) Shares Gap Up - Time to Buy...

Inventiva (NASDAQ:IVA) Upgraded at Truist Financial

Truist Financial raised Inventiva to a "strong-buy" rating in a report on Wednesday...

Inventiva (NASDAQ:IVA) Coverage Initiated by Analysts at Truist Financial

Truist Financial initiated coverage on Inventiva in a research report on Thursday. They issued a "buy" rating and a $13.00 price objective on the stock...

Inventiva (IVA) to Release Earnings on Wednesday

Inventiva (NASDAQ:IVA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 25. (View Earnings Report at...

Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Drops By 20.4%

Inventiva S.A. Sponsored ADR (NASDAQ:IVA - Get Free Report) saw a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 549,755...

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

IVA
Inventiva - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IVA News

IVAInventiva - ADR